- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Barriers to routine G6PD testing prior to treatment with primaquine ; volume:16 ; number:1 ; day:10 ; month:8 ; year:2017 ; pages:1-10 ; date:12.2017
Malaria journal ; 16, Heft 1 (10.8.2017), 1-10, 12.2017
- Klassifikation
-
Soziale Probleme, Sozialdienste, Versicherungen
- Schlagwort
-
Infektion
Infektiologie
- Urheber
-
Ley, Benedikt
- Beteiligte Personen und Organisationen
-
Thriemer, Kamala
Jaswal, Jessica
Poirot, Eugenie
Alam, Mohammad Shafiul
Phru, Ching Swe
Khan, Wasif Ali
Dysoley, Lek
Qi, Gao
Kheong, Chong Chee
Shamsudin, Ummi Kalthom
Chen, Ingrid
Hwang, Jimee
Gosling, Roly
Price, Ric N.
SpringerLink (Online service)
- DOI
-
10.1186/s12936-017-1981-y
- URN
-
urn:nbn:de:1111-2017102618975
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
08.03.2226, 08:12 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ley, Benedikt
- Thriemer, Kamala
- Jaswal, Jessica
- Poirot, Eugenie
- Alam, Mohammad Shafiul
- Phru, Ching Swe
- Khan, Wasif Ali
- Dysoley, Lek
- Qi, Gao
- Kheong, Chong Chee
- Shamsudin, Ummi Kalthom
- Chen, Ingrid
- Hwang, Jimee
- Gosling, Roly
- Price, Ric N.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
Correction to: NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
Correction to: NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies
G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
Spectrophotometry assays to determine G6PD activity from Trinity Biotech and Pointe Scientific G6PD show good correlation
Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
Correction to: NF-κB and pSTAT3 synergistically drive G6PD overexpression and facilitate sensitivity to G6PD inhibition in ccRCC
Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination